USD 3.24
(N/A%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 7.7 Million USD | -67.1% |
2022 | 23.42 Million USD | 60.13% |
2021 | 14.62 Million USD | 5.32% |
2020 | 13.88 Million USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 337 Thousand USD | -94.38% |
2024 Q1 | 6 Million USD | 724.31% |
2023 Q3 | 440 Thousand USD | -82.69% |
2023 Q2 | 2.54 Million USD | -36.37% |
2023 FY | 7.7 Million USD | -67.1% |
2023 Q1 | 3.99 Million USD | 145.69% |
2023 Q4 | 728 Thousand USD | 65.45% |
2022 Q2 | 5.29 Million USD | -35.37% |
2022 Q3 | 8.31 Million USD | 57.26% |
2022 Q4 | 1.62 Million USD | -80.45% |
2022 FY | 23.42 Million USD | 60.13% |
2022 Q1 | 8.18 Million USD | 52.99% |
2021 Q3 | 2.48 Million USD | -25.98% |
2021 Q1 | 3.42 Million USD | -6.62% |
2021 FY | 14.62 Million USD | 5.32% |
2021 Q4 | 5.35 Million USD | 115.12% |
2021 Q2 | 3.36 Million USD | -2.01% |
2020 Q4 | 3.67 Million USD | -4.57% |
2020 FY | 13.88 Million USD | 0.0% |
2020 Q3 | 3.84 Million USD | 20.87% |
2020 Q2 | 3.18 Million USD | 0.0% |
2020 Q1 | 3.18 Million USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
iCoreConnect Inc. | 8.15 Million USD | 5.479% |
Accolade, Inc. | 414.29 Million USD | 98.14% |
Augmedix, Inc. | 44.85 Million USD | 82.822% |
BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 99.913% |
CareCloud, Inc. | 117.05 Million USD | 93.418% |
CareCloud, Inc. | 117.05 Million USD | 93.418% |
Definitive Healthcare Corp. | 251.41 Million USD | 96.935% |
Health Catalyst, Inc. | 295.93 Million USD | 97.396% |
HealthEquity, Inc. | 999.58 Million USD | 99.229% |
HealthStream, Inc. | 279.06 Million USD | 97.239% |
Inovalon Holdings, Inc. | 667.52 Million USD | 98.846% |
Nutex Health, Inc. | 247.64 Million USD | 96.889% |
Omnicell, Inc. | 1.14 Billion USD | 99.328% |
OneMedNet Corporation | 1.02 Million USD | -654.171% |
Progyny, Inc. | 1.08 Billion USD | 99.292% |
Renalytix Plc | 2.28 Million USD | -236.61% |
Schrödinger, Inc. | 216.66 Million USD | 96.444% |
Simulations Plus, Inc. | 70.01 Million USD | 88.995% |
Streamline Health Solutions, Inc. | 22.59 Million USD | 65.901% |
SOPHiA GENETICS SA | 62.37 Million USD | 87.647% |
Ontrak, Inc. | 12.74 Million USD | 39.535% |
Minerva Surgical, Inc. | 50.29 Million USD | 84.68% |
GE HealthCare Technologies Inc. | 19.55 Billion USD | 99.961% |
Sharecare, Inc. | 445.25 Million USD | 98.27% |
Aclarion, Inc. | 75.4 Thousand USD | -10118.291% |
CareMax, Inc. | 751.1 Million USD | 98.974% |
Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -11753.846% |
Forian Inc. | 20.48 Million USD | 62.38% |
Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -11753.846% |
HeartBeam, Inc. | - USD | -Infinity% |
GeneDx Holdings Corp. | 202.56 Million USD | 96.196% |
SCWorx Corp. | 3.8 Million USD | -102.5% |
10x Genomics, Inc. | 618.72 Million USD | 98.755% |
Zhongchao Inc. | 19.43 Million USD | 60.353% |
R1 RCM Inc. | 2.25 Billion USD | 99.658% |
Spok Holdings, Inc. | 139.02 Million USD | 94.458% |
Privia Health Group, Inc. | 1.65 Billion USD | 99.535% |
EUDA Health Holdings Limited | 3.7 Million USD | -107.88% |
TruBridge, Inc. | 339.43 Million USD | 97.73% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 99.913% |
Sharecare, Inc. | 445.25 Million USD | 98.27% |
GoodRx Holdings, Inc. | 750.26 Million USD | 98.973% |
Premier, Inc. | 1.34 Billion USD | 99.428% |
Certara, Inc. | 354.33 Million USD | 97.826% |
GeneDx Holdings Corp. | 202.56 Million USD | 96.196% |
Ontrak, Inc. | 12.74 Million USD | 39.535% |
SHL Telemedicine Ltd. | 57.07 Million USD | 86.5% |
CareCloud, Inc. | 117.05 Million USD | 93.418% |
EUDA Health Holdings Limited | 3.7 Million USD | -107.88% |
HeartBeam, Inc. | - USD | -Infinity% |
Mangoceuticals, Inc. | 731.49 Thousand USD | -953.325% |
CareMax, Inc. | 751.1 Million USD | 98.974% |
Healthcare Triangle, Inc. | 33.2 Million USD | 76.794% |
National Research Corporation | 148.58 Million USD | 94.814% |
Aclarion, Inc. | 75.4 Thousand USD | -10118.291% |
OptimizeRx Corporation | 71.52 Million USD | 89.227% |